Valacyclovir 1000 mg Tablet Under Fed Conditions
Condition(s):HealthyLast Updated:September 14, 2010Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:September 14, 2010Completed
Condition(s):Chronic Lymphocytic Leukemia; CML (Chronic Myelogenous Leukemia); MDS (Myelodysplastic Syndrome); Acute Lymphoblastic Leukemia; AML (Acute Myelogenous Leukemia)Last Updated:December 17, 2019Terminated
Condition(s):Non Small Cell Lung CancerLast Updated:December 7, 2023Active, not recruiting
Condition(s):Refractory Cold Agglutinin DiseaseLast Updated:October 27, 2017Completed
Condition(s):Herpes Simplex Virus InfectionLast Updated:January 19, 2021Completed
Condition(s):PainLast Updated:June 16, 2022Withdrawn
Condition(s):Multiple MyelomaLast Updated:September 22, 2011Unknown status
Condition(s):Age-Related Macular DegenerationLast Updated:January 3, 2024Recruiting
Condition(s):CMV Infection; Hematopoietic Stem Cell TransplantationLast Updated:February 5, 2024Recruiting
Condition(s):Lymphoma; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 24, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.